Zobrazeno 1 - 10
of 17 561
pro vyhledávání: '"Uno, H"'
Publikováno v:
Biomedical Safety & Standards; October 2022, Vol. 52 Issue: 18 p141-141, 1p
Autor:
Bertke, M.H., Dragun, A.E.
Publikováno v:
Breast Diseases: A Year Book Quarterly; 2016, Vol. 27 Issue 1, p73-74, 2p
Autor:
Sakai H; Division of Integrative Pathophysiology, Proteo-Science Center, Ehime University, Toon, Ehime 791-0295, Japan.; Department of Pathophysiology, Ehime University Graduate School of Medicine, Toon, Ehime 791-0295, Japan., Uno H; Department of Pathophysiology, Ehime University Graduate School of Medicine, Toon, Ehime 791-0295, Japan., Yamakawa H; Department of Pathophysiology, Ehime University Graduate School of Medicine, Toon, Ehime 791-0295, Japan., Tanaka K; Division of Transcriptomics, Medical Institute of Bioregulation, Kyushu University, Higashi-ku, Fukuoka 812-0054, Japan., Ikedo A; Division of Integrative Pathophysiology, Proteo-Science Center, Ehime University, Toon, Ehime 791-0295, Japan., Uezumi A; Division of Cell Heterogeneity, Medical Institute of Bioregulation, Kyushu University, Higashi-ku, Fukuoka 812-0054, Japan., Ohkawa Y; Division of Transcriptomics, Medical Institute of Bioregulation, Kyushu University, Higashi-ku, Fukuoka 812-0054, Japan., Imai Y; Division of Integrative Pathophysiology, Proteo-Science Center, Ehime University, Toon, Ehime 791-0295, Japan.; Department of Pathophysiology, Ehime University Graduate School of Medicine, Toon, Ehime 791-0295, Japan.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Sep 24; Vol. 121 (39), pp. e2407768121. Date of Electronic Publication: 2024 Sep 18.
Autor:
Hantel A; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Cernik C; Dana-Farber Cancer Institute, Boston, Massachusetts., Walsh TP; Dana-Farber Cancer Institute, Boston, Massachusetts., Uno H; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Larios D; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Boston., Slutzman JE; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Boston., Abel GA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Sep 01; Vol. 10 (9), pp. 1245-1252.
Autor:
Wong JS; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Uno H; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Tramontano AC; Dana-Farber Cancer Institute, Boston, Massachusetts., Fisher L; Dana-Farber Cancer Institute, Boston, Massachusetts., Pellegrini CV; Dana-Farber Cancer Institute, Boston, Massachusetts., Abel GA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Burstein HJ; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Chun YS; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., King TA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Schrag D; Memorial Sloan Kettering Cancer Center, New York, New York., Winer E; Yale Cancer Center, New Haven, Connecticut., Bellon JR; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Cheney MD; Maine Medical Center, Portland, Maine., Hardenbergh P; Vail Health, Vail, Colorado., Ho A; Duke University Medical Center, Durham, North Carolina., Horst KC; Stanford University School of Medicine, Stanford, California., Kim JN; Fred Hutchinson Cancer Center/UW Medicine, Seattle, Washington., Leonard KL; Warren Alpert Medical School of Brown University, Providence, Rhode Island.; Rhode Island Hospital, Providence., Moran MS; Yale Cancer Center, New Haven, Connecticut., Park CC; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Recht A; Harvard Medical School, Boston, Massachusetts.; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Soto DE; Massachusetts General Hospital, Boston., Shiloh RY; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Stinson SF; Johns Hopkins School of Medicine, Baltimore, Maryland., Snyder KM; Northern Light Health, Brewer, Maine., Taghian AG; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Boston., Warren LE; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Wright JL; Johns Hopkins School of Medicine, Baltimore, Maryland., Punglia RS; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08.
Autor:
Cui Y; Department of Biomedical Data Science, Stanford University, Stanford, CA, USA., Huang B; Pfizer Research & Development, Pfizer Inc, Groton, CT, USA., Mao L; Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA., Uno H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Wei LJ; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA., Tian L; Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.
Publikováno v:
Clinical trials (London, England) [Clin Trials] 2024 Aug 08, pp. 17407745241264188. Date of Electronic Publication: 2024 Aug 08.
Autor:
Mack JW; Division of Population Sciences, Department of Medical Oncology, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Cernik C; Division of Population Sciences, Department of Medical Oncology, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Xu L; MedHealth Statistical Consulting Inc, Solon, OH, USA., Laurent CA; Division of Research, Department of Research and Evaluation, Kaiser Permanente Northern California, Oakland, CA, USA., Fisher L; Division of Population Sciences, Department of Medical Oncology, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Cannizzaro N; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Munneke J; Division of Research, Department of Research and Evaluation, Kaiser Permanente Northern California, Oakland, CA, USA., Cooper RM; Department of Pediatric Oncology, Kaiser Permanente Southern California, Pasadena, CA, USA., Lakin JR; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, USA., Schwartz CM; Division of Medical Oncology, Department of Medicine, Kaiser Permanente Northern California, Oakland, CA, USA., Casperson M; Cactus Cancer Society (cactuscancer.org, MC), Oakland, CA, USA., Altschuler A; Division of Research, Department of Research and Evaluation, Kaiser Permanente Northern California, Oakland, CA, USA., Wiener L; Psychosocial Support and Research Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Kushi LH; Division of Research, Department of Research and Evaluation, Kaiser Permanente Northern California, Oakland, CA, USA., Chao CR; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Uno H; Division of Population Sciences, Department of Medical Oncology, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Jul 01; Vol. 116 (7), pp. 1080-1086.
Autor:
Uno H; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA., Horiguchi M; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Jul; Vol. 8, pp. e2400358.
Autor:
Watanabe H; Department of Orthopaedic Surgery, Fujita Health University, Toyoake, Aichi, Japan., Xu W; Faculty of Advanced Science and Technology, Kumamoto University, Kumamoto, Japan., Uno H; Faculty of Advanced Science and Technology, Kumamoto University, Kumamoto, Japan., Uraya Y; Department of Orthopaedic Surgery, Fujita Health University, Toyoake, Aichi, Japan., Kugita M; Advanced Medical Research Center for Animal Models of Human Diseases, Research Promotion Headquarters, Fujita Health University, Toyoake, Aichi, Japan., Komohara Y; Department of Cell Pathology, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan., Niidome T; Faculty of Advanced Science and Technology, Kumamoto University, Kumamoto, Japan., Sasaki M; Faculty of Advanced Science and Technology, Kumamoto University, Kumamoto, Japan., Shimizu I; Department of Mechanical Engineering, Okayama University of Science, Okayama, Japan., Fujita N; Department of Orthopaedic Surgery, Fujita Health University, Toyoake, Aichi, Japan., Kawano Y; Department of Orthopaedic Surgery, Fujita Health University, Toyoake, Aichi, Japan.
Publikováno v:
Journal of biomedical materials research. Part A [J Biomed Mater Res A] 2024 Jul; Vol. 112 (7), pp. 963-972. Date of Electronic Publication: 2024 Jan 18.
Autor:
Paudel R; Dana-Farber Cancer Institute, Boston, MA, USA., Enzinger AC; Dana-Farber Cancer Institute, Boston, MA, USA., Uno H; Dana-Farber Cancer Institute, Boston, MA, USA., Cronin C; Dana-Farber Cancer Institute, Boston, MA, USA., Wong SL; Dartmouth Hitchcock Medical Center, Lebanon, NH, USA., Dizon DS; Lifespan Cancer Institute and Brown University, Providence, RI, USA., Hazard Jenkins H; West Virginia University Cancer Center, Morgantown, WV, USA., Bian J; Maine Medical Center, Portland, ME, USA., Osarogiagbon RU; Baptist Medical Center, Memphis, TN, USA., Jensen RE; National Cancer Institute, Rockville, MD, USA., Mitchell SA; National Cancer Institute, Rockville, MD, USA., Schrag D; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hassett MJ; Dana-Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Jul 01; Vol. 116 (7), pp. 1137-1144.